 CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Sept. 09, 2021 GLOBE NEWSWIRE -- F-star Therapeutics, Inc. NASDAQ: FSTX, a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to transform the lives of patients with cancer, announced today that F-star will participate next week at the H. C. Wainwright 23rd Annual Global Investment Conference, taking place virtually September 13-15. 